477 related articles for article (PubMed ID: 18332662)
1. Tardive dyskinesia and new antipsychotics.
Correll CU; Schenk EM
Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662
[TBL] [Abstract][Full Text] [Related]
2. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Correll CU; Leucht S; Kane JM
Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
[TBL] [Abstract][Full Text] [Related]
3. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS
J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
6. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients.
Dolder CR; Jeste DV
Biol Psychiatry; 2003 Jun; 53(12):1142-5. PubMed ID: 12814866
[TBL] [Abstract][Full Text] [Related]
7. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
Woods SW; Morgenstern H; Saksa JR; Walsh BC; Sullivan MC; Money R; Hawkins KA; Gueorguieva RV; Glazer WM
J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
[TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia rates with atypical antipsychotics in older adults.
Jeste DV
J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
[TBL] [Abstract][Full Text] [Related]
9. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management.
Widschwendter CG; Hofer A
Curr Opin Psychiatry; 2019 May; 32(3):179-184. PubMed ID: 30720484
[TBL] [Abstract][Full Text] [Related]
11. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
Szafrański T
Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
[TBL] [Abstract][Full Text] [Related]
12. One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review.
Correll CU; Kane JM
J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):647-56. PubMed ID: 17979584
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
[TBL] [Abstract][Full Text] [Related]
14. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
[TBL] [Abstract][Full Text] [Related]
15. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
Miller DD; Eudicone JM; Pikalov A; Kim E
J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
[TBL] [Abstract][Full Text] [Related]
18. Managing antipsychotic-induced tardive dyskinesia.
Gardos G
Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia and second-generation antipsychotics.
Saraf S; Chandra PS
Am J Psychiatry; 2005 Feb; 162(2):404-5; author reply 405-6. PubMed ID: 15677619
[No Abstract] [Full Text] [Related]
20. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
